Return to Growth in 2026: Long-term accomplished founder and management have shepherded SBC from a solo clinic in 2000 to become a global cosmetic treatment center franchiser and cash generation machine with little debt. Near-term revenue growth decline in 2025 on near-term pricing pressures (reflecting increased market competition pressure) is expected to end in early-2026. Looking through the valley then sees the Company growing again this year with additional prospects for global M&A in addition to Japanese M&A as well as AI and longevity initiatives.
